Category Research

AbbVie and OSE Immunotherapeutics Collaborate to Advance Novel Monoclonal Antibody for Chronic Inflammation Treatment

AbbVie Inc. (NYSE: ABBV) and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage immunotherapy company, have announced a strategic partnership aimed at developing OSE-230, a monoclonal antibody designed to address chronic and severe inflammation. Currently in the pre-clinical development…

Read MoreAbbVie and OSE Immunotherapeutics Collaborate to Advance Novel Monoclonal Antibody for Chronic Inflammation Treatment

FDA Prioritizes Review of Dupixent® sable for COPD Treatment Targeting Type 2 Inflammation

The U.S. Food and Drug Administration (FDA) has given priority review status to the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab), marking its sixth potential indication. This review targets its use as an add-on maintenance treatment for specific adult…

Read MoreFDA Prioritizes Review of Dupixent® sable for COPD Treatment Targeting Type 2 Inflammation

Revised WHO Recommendations for Managing Vector-Borne Diseases via Indoor Residual Spraying

Approximately 80% of the global population faces the threat of contracting one or more vector-borne diseases, with mosquitoes, flies, bugs, and other vectors transmitting viruses, parasites, and bacteria to millions worldwide. These diseases, including malaria, dengue, Chikungunya, yellow fever, Zika…

Read MoreRevised WHO Recommendations for Managing Vector-Borne Diseases via Indoor Residual Spraying

Practical Two Day FDA Inspection Online Seminar – Research AndMarkets.com

ResearchAndMarkets.com is pleased to announce the addition of “FDA Inspection” training to its offerings. This two-day seminar is meticulously crafted to equip professionals in the pharmaceutical, biopharmaceutical, biologics, and medical device industries with the essential knowledge and tools to adeptly…

Read MorePractical Two Day FDA Inspection Online Seminar – Research AndMarkets.com

European Commission Approves CASGEVY™ for SCD and TDT Treatment

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company dedicated to pioneering gene-based treatments for severe illnesses, disclosed today that the European Commission has granted conditional marketing authorization for CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy. CASGEVY has been cleared for…

Read MoreEuropean Commission Approves CASGEVY™ for SCD and TDT Treatment

New Findings from Phase 3 Trials of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa to be Revealed at EHSF 2024

Results from the latest analyses of bimekizumab phase 3 trials in patients with moderate to severe hidradenitis suppurativa (HS) will be presented at the 13th Conference of the European Hidradenitis Suppurativa Foundation (EHSF) in Lyon, France (February 7-9, 2024). UCB,…

Read MoreNew Findings from Phase 3 Trials of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa to be Revealed at EHSF 2024

Novartis Secures Approval for Expanded Paediatric Chronic Heart Failure Indication for Entrust® Tablet, an Angiotensin Receptor Neprilysin Inhibitor (ARNI)

Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that Novartis Pharma K.K. (Novartis Pharma) has received approval for an expanded treatment indication of pediatric chronic heart failure for Entresto® Tablets, an angiotensin receptor neprilysin inhibitor (ARNI) available in 50 mg, 100 mg,…

Read MoreNovartis Secures Approval for Expanded Paediatric Chronic Heart Failure Indication for Entrust® Tablet, an Angiotensin Receptor Neprilysin Inhibitor (ARNI)

Biotech and Autoloops Forge Partnership for Advancing CAR-T Cell Therapy Pipeline and Scaling Late-Stage Initiatives

 BioNTech SE (Nasdaq: BNTX, “BioNTech”), a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, and Autolus Therapeutics plc (Nasdaq: AUTL, “Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a strategic collaboration aimed at advancing…

Read MoreBiotech and Autoloops Forge Partnership for Advancing CAR-T Cell Therapy Pipeline and Scaling Late-Stage Initiatives